Focal cortical dysplasia (FCD) is the most frequent etiology of operable pharmacoresistant
epilepsy in children. There is burgeoning evidence that FCD‐related epilepsy is a disorder …

Bottom-of-sulcus dysplasia (BOSD) is increasingly recognized as a cause of drug-resistant,
surgically-remediable, focal epilepsy, often in seemingly MRI-negative patients. We describe …

Epilepsy's myriad causes and clinical presentations ensure that accurate diagnoses and
targeted treatments remain a challenge. Advanced neurotechnologies are needed to better …

Focal cortical dysplasia (FCD) type II is a highly epileptogenic developmental malformation
and a common cause of surgically treated drug-resistant epilepsy. While clinical …

Objective To determine common network alterations in focal cortical dysplasia
pharmacoresistant epilepsy (FCD‐PRE) using functional connectivity analysis of resting …

Objective Patients with focal, lesional epilepsy present with seizures at variable ages. Larger
lesion size and overlap with sensorimotor or default mode network (DMN) have been …

Objective The purpose of this study was to evaluate the performance and generalizability of
an automated, interpretable surface-based MRI classifier for the detection of focal cortical …

Objectives To investigate the characteristics of brain structure in children with focal cortical
dysplasia (FCD)-induced pharmacoresistant epilepsy, and explore the potential …

Epilepsy is a complex, multifaceted disease that affects patients in several ways in addition
to seizures, including psychological, social, and quality of life issues, but epilepsy is also …

To evaluate the role of focal cortical dysplasia co‐localization to cortical functional networks
in the development of pharmacoresistance. One hundred thirty‐six focal cortical dysplasia …